Why Male Partners Should Get Tested Early — Not as a Last Resort

There is a common and largely unhelpful pattern in how fertility evaluation unfolds for many couples: extensive testing for the female partner happens first, sometimes over months, before male testing is even mentioned. This sequencing is not medically necessary, is often not what current guidelines actually recommend, and can add significant unnecessary time and emotional weight to a process that could move considerably faster with a different approach.

WHAT CURRENT GUIDELINES ACTUALLY SAY

Medical guidelines from organizations including the American Society for Reproductive Medicine recommend that semen analysis be part of the initial workup for any couple beginning fertility evaluation — not a step reserved for after female testing has been completed or exhausted. This makes clinical sense: a semen analysis is inexpensive, minimally invasive, and provides significant diagnostic information quickly, relative to some of the female fertility testing that can take longer to complete and interpret.

If your fertility evaluation has begun with extensive testing for one partner while the other partner's evaluation hasn't been mentioned or has been deferred, it is entirely appropriate to ask directly: "should we also be doing a semen analysis now, given that current guidelines recommend testing both partners early in the process?"

WHY THE OLD SEQUENCING PERSISTS ANYWAY

Despite guidelines recommending early dual testing, the cultural pattern of treating infertility as primarily a female medical issue persists in some clinical practice, sometimes reflecting outdated training, sometimes reflecting assumptions about which partner is more motivated to pursue testing quickly, and sometimes simply reflecting institutional inertia rather than any deliberate clinical reasoning. None of these reasons are good ones, and none of them should determine the pace or sequencing of your own evaluation.

WHAT EARLY TESTING ACTUALLY CHANGES

Getting a semen analysis early means you have a complete diagnostic picture from the start, rather than discovering male factor contributions after months of testing focused exclusively on the female partner — testing that, in hindsight, might have been sequenced differently with fuller information from the beginning. It also means both partners are genuinely engaged as participants in the evaluation from day one, rather than one partner being positioned as the primary patient and the other as a supporting figure who becomes involved later.

There is also a real time-efficiency argument: if male factor is identified early, it can shape the entire treatment approach appropriately from the start — potentially avoiding cycles of IUI that are unlikely to succeed given a significant male factor finding, and moving more directly to the approach (often ICSI with IVF) that's actually most likely to be effective given the full picture.

ADDRESSING THE DISCOMFORT DIRECTLY

Part of why male testing sometimes gets deferred is genuine discomfort — both from men who may feel anxious about the test and its results, and sometimes from a broader cultural discomfort with directly addressing male fertility as a clinical topic requiring equal attention. This discomfort is understandable and worth naming, but it shouldn't determine clinical sequencing. A semen analysis is a routine, well-understood medical test, and treating it as equally important and equally routine as any female fertility testing — rather than as an emotionally loaded afterthought — tends to reduce the anxiety around it over time, both for the individual and for the broader cultural pattern this reflects.

HOW TO ADVOCATE FOR THIS AS A COUPLE

If you're early in your fertility journey and haven't yet had both partners' testing initiated, it's entirely reasonable to bring this up directly at your next appointment: "we'd like to move forward with testing for both of us now, rather than sequentially." Most reproductive specialists will readily accommodate this request, since it aligns with actual clinical guidelines; if a provider seems resistant to testing both partners early without a clear clinical reason, that's worth noting as you consider whether this provider is the right long-term fit for your care.

WHAT THIS SAYS ABOUT HOW TOGARA APPROACHES FERTILITY

This sequencing issue reflects something larger that Togara is built around: the assumption that infertility is primarily a female medical experience, with the male partner as a secondary or supporting figure, is outdated and doesn't reflect either the clinical reality (where male factor contributes to a substantial share of cases) or the lived reality of couples navigating this together. Advocating for equal, early testing for both partners is a small but meaningful way of insisting on that equal partnership from the very first steps of the process.

REFLECT TOGETHER:

If you haven't yet both had initial fertility testing, discuss bringing this up directly at your next appointment — using the specific language above if it helps to have exact words ready.

Verification note: Current ASRM guidelines recommend semen analysis as part of initial fertility evaluation for couples. Specific testing sequencing may vary by individual clinical circumstances — discuss your specific situation with your healthcare provider.